Fluvoxamine

Generic name: Pronounced as (floo vox' a meen)
Brand names
  • Luvox®
  • Luvox® CR
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 01/15/2022

A small number of children, teenagers, and young adults (up to 24 years of age) who took antidepressants ('mood elevators') such as fluvoxamine during clinical studies became suicidal (thinking about harming or killing oneself or planning or trying to do so). Children, teenagers, and young adults who take antidepressants to treat depression or other mental illnesses may be more likely to become suicidal than children, teenagers, and young adults who do not take antidepressants to treat these conditions. However, experts are not sure about how great this risk is and how much it should be considered in deciding whether a child or teenager should take an antidepressant.

You should know that your mental health may change in unexpected ways when you take fluvoxamine or other antidepressants even if you are an adult over 24 years of age. You may become suicidal, especially at the beginning of your treatment and any time that your dose is increased or decreased. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: new or worsening depression; thinking about harming or killing yourself, or planning or trying to do so; extreme worry; agitation; panic attacks; difficulty falling asleep or staying asleep; aggressive behavior; irritability; acting without thinking; severe restlessness; and frenzied abnormal excitement. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor if you are unable to seek treatment on your own.

Your healthcare provider will want to see you often while you are taking fluvoxamine, especially at the beginning of your treatment. Be sure to keep all appointments for office visits with your doctor.

The doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with fluvoxamine. Read the information carefully and ask your doctor or pharmacist if you have any questions. You also can obtain the Medication Guide from the FDA website: http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm.

No matter your age, before you take an antidepressant, you, your parent, or your caregiver should talk to your doctor about the risks and benefits of treating your condition with an antidepressant or with other treatments. You should also talk about the risks and benefits of not treating your condition. You should know that having depression or another mental illness greatly increases the risk that you will become suicidal. This risk is higher if you or anyone in your family has or has ever had bipolar disorder (mood that changes from depressed to abnormally excited) or mania (frenzied, abnormally excited mood) or has thought about or attempted suicide. Talk to your doctor about your condition, symptoms, and personal and family medical history. You and your doctor will decide what type of treatment is right for you.

Fluvoxamine is used to treat obsessive-compulsive disorder (bothersome thoughts that won't go away and the need to perform certain actions over and over) and social anxiety disorder (extreme fear of interacting with others or performing in front of others that interferes with normal life). Fluvoxamine is in a class of medications called selective serotonin reuptake inhibitors (SSRIs). It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.

Fluvoxamine comes as a tablet and an extended-release capsule to take by mouth. The tablet usually is taken either once daily at bedtime or twice daily, once in the morning and once at bedtime. The extended-release capsule usually is taken, with or without food , once daily at bedtime. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take fluvoxamine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the extended-release capsules whole; do not be crush or chew them.

Your doctor may start you on a low dose of fluvoxamine and gradually increase your dose, not more often than once every week, depending on how well the medication works for you and the side effects you experience.

It may take several weeks or longer for you to feel the full benefit of fluvoxamine. Continue to take fluvoxamine even if you feel well. Do not stop taking fluvoxamine without talking to your doctor. If you suddenly stop taking fluvoxamine, you may experience withdrawal symptoms such as irritability; agitation; dizziness; extreme worry; uneasiness; confusion; headache; tiredness; mood changes; difficulty falling asleep or staying asleep; or pain, burning, numbness, tingling or 'electric shock' sensations in the hands or feet. Your doctor probably will decrease your dose gradually.

Fluvoxamine is also used sometimes to treat depression. Talk with your doctor about the possible risks of using this medication for your condition.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking fluvoxamine,

  • tell your doctor and pharmacist if you are allergic to fluvoxamine, any other medications, or any of the ingredients in fluvoxamine tablets and extended-release capsules. Ask your doctor or pharmacist for a list of the ingredients..

  • tell your doctor if you are taking alosetron (Lotronex), pimozide (Orap), ramelteon (Rozerem), tizanidine (Zanaflex), or thioridazine. Your doctor will probably tell you not to take fluvoxamine.

  • tell your doctor if you are taking the following medications or if you have stopped taking them within the past 14 days: monoamine oxidase (MAO) inhibitors such as isocarboxazid (Marplan), linezolid (Zyvox), methylene blue; phenelzine (Nardil), rasagiline (Azilect), selegiline (Emsam, Zelapar), and tranylcypromine (Parnate). Your doctor will probably tell you not to take fluvoxamine. If you stop taking fluvoxamine, you should wait at least 14 days before you start to take an MAO inhibitor.

  • tell your doctor and pharmacist what prescription and nonprescription medications, and vitamins you are taking or plan to take. Be sure to mention any of the following: alprazolam (Xanax); amphetamines; anticoagulants ('blood thinners') such as warfarin (Coumadin); aspirin or aspirin-containing products and other nonsteroidal anti-inflammatory drugs such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); beta-blockers such as metoprolol (Lopressor, Toprol) and propranolol (Hemangeol, Inderal, Innopran); buspirone; carbamazepine (Carbatrol, Equetro, Tegretol, others); clozapine (Clozaril, Versacloz); cyclosporine (Neoral, Sandimmune); dextromethorphan (in cough medications); diazepam (Valium, Valtoco); diltiazem (Cardizem, Cartia, Tiazac, others); diuretics ('water pills'); fentanyl (Abstral, Actiq, Fentora, Onsolis, others); haloperidol (Haldol); ketoconazole; lithium (Lithobid); medications for migraine headaches such as almotriptan (Axert), eletriptan (Relpax), frovatriptan (Frova), naratriptan, rizatriptan (Maxalt), sumatriptan (Imitrex), and zolmitriptan (Zomig); methadone (Methadose); mexiletine; metoclopramide; midazolam (Seizalam); omeprazole (Prilosec, Zegerid); other medications for anxiety, depression, or mental illness; phenytoin (Dilantin, Phenytek); tacrine (Cognex); theophylline (Theo-24, Theochron); tramadol (Conzip, Qdolo, Ultram, in Ultracet); triazolam (Halcion); and quinidine. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with fluvoxamine, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor what herbal products and nutritional supplements you are taking, especially products that contain St. John's wort and tryptophan.

  • tell your doctor if you drink or have ever drunk large amounts of alcohol or have used street drugs or have overused prescription medications. Also tell your doctor if you have recently had a heart attack, if you have low sodium levels in the blood; or if you have or have ever had bleeding problems; seizures; or heart, kidney, or liver disease.

  • tell your doctor if you are pregnant, especially if you are in the last few months of your pregnancy, or if you plan to become pregnant or are breast-feeding. If you become pregnant while taking fluvoxamine, call your doctor. Fluvoxamine may cause problems in newborns following delivery if it is taken during the last months of pregnancy.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking fluvoxamine.

  • you should know that this medication may make you drowsy or affect your judgment, thinking, or motor skills. Do not drive a car or operate machinery until you know how this medication affects you.

  • remember that alcohol can add to the drowsiness caused by this medication. You should not drink alcohol while taking fluvoxamine.

  • tell your doctor if you use tobacco products. Cigarette smoking may decrease the effectiveness of this medication.

  • you should know that fluvoxamine may cause angle-closure glaucoma (a condition where the fluid is suddenly blocked and unable to flow out of the eye causing a quick, severe increase in eye pressure which may lead to a loss of vision). Talk to your doctor about having an eye examination before you start taking this medication. If you have nausea, eye pain, changes in vision, such as seeing colored rings around lights, and swelling or redness in or around the eye, call your doctor or get emergency medical treatment right away.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Fluvoxamine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • drowsiness

    • dry mouth

    • nausea

    • vomiting

    • diarrhea

    • stomach pain

    • constipation

    • indigestion

    • gas

    • change in taste

    • stuffy nose

    • decreased appetite

    • sweating

    • difficulty falling asleep or staying asleep

    • weight loss

    • nervousness

    • sexual problems in males; decreased sex drive, inability to get or keep an erection, or delayed or absent ejaculation

    • sexual problems in females; decreased sex drive, or delayed orgasm or unable to have an orgasm

  • Some side effects can be serious. If you experience any of the following symptoms, or those listed in the IMPORTANT WARNING or SPECIAL PRECAUTIONS sections, call your doctor immediately or get emergency medical treatment:

    • dizziness

    • fever, sweating, confusion, fast or irregular heartbeat, and severe muscle stiffness or twitching, agitation, hallucinations, loss of coordination, nausea, vomiting, or diarrhea

    • pain, burning, numbness, or tingling in the hands or feet

    • shaking of a part of the body that you cannot control

    • headache

    • difficulty concentrating

    • difficulty concentrating, memory problems, or confusion

    • weakness

    • unsteadiness

    • rash

    • hives

    • swelling of the eyes, face, lips, tongue, or throat

    • slowed or difficult breathing

    • seizures

    • loss of consciousness

    • unusual bleeding or bruising

    • bloody nose

    • vomiting blood or a material that looks like coffee grounds

    • red blood in stool or black and tarry stools

  • Fluvoxamine may decrease appetite and cause weight loss in children. Your child's doctor will watch his or her growth carefully. Talk to your child's doctor if you have concerns about your child's growth or weight while he or she is taking this medication. Talk to your child's doctor about the risks of giving fluvoxamine to your child.

  • Fluvoxamine may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • drowsiness

  • agitation, hallucinations, fever, sweating, confusion, fast heartbeat, shivering, severe muscle stiffness or twitching, loss of coordination, nausea, vomiting, or diarrhea

  • excessive tiredness

  • dizziness

  • agitation

  • mania

  • seizures

  • loss of consciousness

It is important to keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your response to fluvoxamine.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Fluvoxamine can be decreased when combined with Moxifloxacin.
Repaglinide Repaglinide The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Repaglinide.
Montelukast Montelukast The metabolism of Montelukast can be decreased when combined with Fluvoxamine.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Fluvoxamine can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Fluvoxamine can be decreased when it is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Fluvoxamine can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Fluvoxamine can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Fluvoxamine.
Dolasetron Dolasetron The metabolism of Fluvoxamine can be decreased when combined with Dolasetron.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Fluvoxamine.
Anagrelide Anagrelide The metabolism of Anagrelide can be decreased when combined with Fluvoxamine.
Candesartan Candesartan The metabolism of Candesartan can be decreased when combined with Fluvoxamine.
Cilostazol Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Fluvoxamine.
Clopidogrel Clopidogrel The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Fluvoxamine resulting in a loss in efficacy.
Diphenoxylate Diphenoxylate The risk or severity of serotonin syndrome can be increased when Diphenoxylate is combined with Fluvoxamine.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole Erythromycin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Conjugated estrogens can be decreased when combined with Fluvoxamine.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Fluvoxamine.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Guanfacine is combined with Fluvoxamine.
Magnesium Hydroxide Magnesium Hydroxide Fluvoxamine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Miglitol Miglitol The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Miglitol.
Mycophenolate Mycophenolate Fluvoxamine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Fluvoxamine.
Olsalazine Olsalazine The risk or severity of gastrointestinal bleeding can be increased when Olsalazine is combined with Fluvoxamine.
Paregoric Paregoric The risk or severity of serotonin syndrome can be increased when Morphine is combined with Fluvoxamine.
Penbutolol Penbutolol The metabolism of Acebutolol can be decreased when combined with Fluvoxamine.
Pentazocine Pentazocine The risk or severity of serotonin syndrome can be increased when Pentazocine is combined with Fluvoxamine.
Potassium Potassium Potassium may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Fluvoxamine may decrease the excretion rate of Prednisone which could result in a higher serum level.
Ranitidine Ranitidine The metabolism of Ranitidine can be decreased when combined with Fluvoxamine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Reserpine.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Rizatriptan.
Sumatriptan Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Fluvoxamine.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Fluvoxamine.
Tizanidine Tizanidine The risk or severity of hypotension can be increased when Fluvoxamine is combined with Tizanidine.
Triamcinolone Triamcinolone The metabolism of Triamcinolone can be decreased when combined with Fluvoxamine.
Zolmitriptan Zolmitriptan The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Zolmitriptan.
Ampicillin Injection Ampicillin Injection Fluvoxamine may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Fluvoxamine may decrease the excretion rate of Doxycycline which could result in a higher serum level.
Famotidine Injection Famotidine Injection The metabolism of Fluvoxamine can be decreased when combined with Famotidine.
Fluconazole Injection Fluconazole Injection Fluvoxamine may decrease the excretion rate of Fluconazole which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Fluvoxamine.
Interferon Beta-1b Injection Interferon Beta-1b Injection The metabolism of Fluvoxamine can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The metabolism of Fluvoxamine can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection Levofloxacin Injection The metabolism of Fluvoxamine can be decreased when combined with Levofloxacin.
Meperidine Injection Meperidine Injection The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Fluvoxamine.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Fluvoxamine.
Morphine Injection Morphine Injection The risk or severity of serotonin syndrome can be increased when Morphine is combined with Fluvoxamine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Fluvoxamine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The metabolism of Zidovudine can be decreased when combined with Fluvoxamine.
Altretamine Altretamine Amphetamine may increase the serotonergic activities of Fluvoxamine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Fluvoxamine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Fluvoxamine.
Enoxaparin Injection Enoxaparin Injection The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Fluvoxamine.
Torsemide Torsemide The metabolism of Torasemide can be decreased when combined with Fluvoxamine.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Fluvoxamine.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Fluvoxamine.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Fluvoxamine.
Hydroxychloroquine Hydroxychloroquine The metabolism of Fluvoxamine can be decreased when combined with Hydroxychloroquine.
Meloxicam Meloxicam The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Meloxicam.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Fluvoxamine.
Pantoprazole Pantoprazole The metabolism of Pantoprazole can be decreased when combined with Fluvoxamine.
Telmisartan Telmisartan Fluvoxamine may decrease the excretion rate of Telmisartan which could result in a higher serum level.
Temozolomide Temozolomide Fluvoxamine may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Zaleplon is combined with Fluvoxamine.
Anakinra Anakinra The metabolism of Fluvoxamine can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Fluvoxamine.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Fluvoxamine.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Pentosan polysulfate.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Fluvoxamine.
Etanercept Injection Etanercept Injection The metabolism of Fluvoxamine can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Fluvoxamine can be increased when combined with Armodafinil.
Perindopril Perindopril Fluvoxamine may decrease the excretion rate of Perindopril which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of gastrointestinal bleeding can be increased when Choline magnesium trisalicylate is combined with Fluvoxamine.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Fluvoxamine.
Eplerenone Eplerenone The metabolism of Eplerenone can be decreased when combined with Fluvoxamine.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Escitalopram.
Olmesartan Olmesartan Olmesartan may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Zonisamide Zonisamide The metabolism of Zonisamide can be decreased when combined with Fluvoxamine.
Adalimumab Injection Adalimumab Injection The metabolism of Fluvoxamine can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Fluvoxamine.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Fluvoxamine.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Fluvoxamine.
Ezetimibe Ezetimibe Fluvoxamine may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Teriparatide Injection Teriparatide Injection The therapeutic efficacy of Teriparatide can be decreased when used in combination with Fluvoxamine.
Atazanavir Atazanavir The metabolism of Fluvoxamine can be decreased when combined with Atazanavir.
Almotriptan Almotriptan The metabolism of Fluvoxamine can be decreased when combined with Almotriptan.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Fluvoxamine.
Mefloquine Mefloquine The metabolism of Fluvoxamine can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Fluvoxamine.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Fluvoxamine.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Fluvoxamine.
Aprepitant Aprepitant The metabolism of Aprepitant can be decreased when combined with Fluvoxamine.
Emtricitabine Emtricitabine Fluvoxamine may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Fluvoxamine can be decreased when combined with Interferon beta-1a.
Memantine Memantine Fluvoxamine may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod Tegaserod The metabolism of Tegaserod can be decreased when combined with Fluvoxamine.
Tadalafil Tadalafil Fluvoxamine may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Fluvoxamine.
Gemifloxacin Gemifloxacin The metabolism of Fluvoxamine can be decreased when combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Progesterone can be decreased when combined with Fluvoxamine.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Fluvoxamine.
Infliximab Injection Infliximab Injection The metabolism of Fluvoxamine can be increased when combined with Infliximab.
Protriptyline Protriptyline The metabolism of Protriptyline can be decreased when combined with Fluvoxamine.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Fluvoxamine.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Fluvoxamine.
Tinidazole Tinidazole Fluvoxamine may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Trospium Trospium Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan Bosentan may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Cefditoren Cefditoren Fluvoxamine may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Fluvoxamine.
Cyanocobalamin Injection Cyanocobalamin Injection Fluvoxamine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Fluvoxamine.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Fluvoxamine is combined with Eszopiclone.
Ganciclovir Ganciclovir Fluvoxamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Insulin aspart.
Ribavirin Ribavirin Fluvoxamine may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The metabolism of Solifenacin can be decreased when combined with Fluvoxamine.
Valganciclovir Valganciclovir Fluvoxamine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Voriconazole can be decreased when combined with Fluvoxamine.
Adefovir Adefovir Adefovir may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may increase the serotonergic activities of Fluvoxamine.
Entecavir Entecavir The metabolism of Entecavir can be decreased when combined with Fluvoxamine.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The metabolism of Fluvoxamine can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Fluvoxamine can be increased when it is combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Pramlintide.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.
Exenatide Injection Exenatide Injection The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Exenatide.
Isocarboxazid Isocarboxazid Fluvoxamine may increase the serotonergic activities of Isocarboxazid.
Ramelteon Ramelteon The serum concentration of Ramelteon can be increased when it is combined with Fluvoxamine.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Fluvoxamine.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Fluvoxamine.
Pregabalin Pregabalin The therapeutic efficacy of Fluvoxamine can be increased when used in combination with Pregabalin.
Deferasirox Deferasirox The serum concentration of Fluvoxamine can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine The metabolism of Fluvoxamine can be increased when combined with Phenylephrine.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Fluvoxamine.
Felbamate Felbamate The risk or severity of adverse effects can be increased when Felbamate is combined with Fluvoxamine.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Insulin detemir.
Ranolazine Ranolazine The metabolism of Ranolazine can be decreased when combined with Fluvoxamine.
Abatacept Injection Abatacept Injection The metabolism of Fluvoxamine can be increased when combined with Abatacept.
Rasagiline Rasagiline The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Fluvoxamine.
Sitagliptin Sitagliptin The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Sitagliptin.
Varenicline Varenicline Fluvoxamine may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib The metabolism of Gefitinib can be decreased when combined with Fluvoxamine.
Albuterol Albuterol Fluvoxamine may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone The metabolism of Paliperidone can be decreased when combined with Fluvoxamine.
Bortezomib Bortezomib The metabolism of Bortezomib can be decreased when combined with Fluvoxamine.
Clofarabine Injection Clofarabine Injection Fluvoxamine may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Fluvoxamine can be increased when combined with Insulin glulisine.
Lubiprostone Lubiprostone Fluvoxamine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Fluvoxamine.
Pemetrexed Injection Pemetrexed Injection The metabolism of Pemetrexed can be decreased when combined with Fluvoxamine.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Fluvoxamine.
Lisdexamfetamine Lisdexamfetamine The metabolism of Lisdexamfetamine can be decreased when combined with Fluvoxamine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Fluvoxamine.
Sorafenib Sorafenib The metabolism of Sorafenib can be decreased when combined with Fluvoxamine.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Fluvoxamine.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Fluvoxamine.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Levocetirizine is combined with Fluvoxamine.
Pegaptanib Injection Pegaptanib Injection Fluvoxamine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Fluvoxamine.
Mexiletine Mexiletine The metabolism of Mexiletine can be decreased when combined with Fluvoxamine.
Armodafinil Armodafinil The metabolism of Fluvoxamine can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Fluvoxamine may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Fluvoxamine.
Lenalidomide Lenalidomide Fluvoxamine may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Fluvoxamine can be decreased when combined with Nilotinib.
Bexarotene Bexarotene The metabolism of Bexarotene can be decreased when combined with Fluvoxamine.
Budesonide Budesonide Fluvoxamine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Desmopressin Desmopressin The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Desmopressin.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Fluvoxamine.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluvoxamine.
Doripenem Injection Doripenem Injection Fluvoxamine may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The metabolism of Etravirine can be decreased when combined with Fluvoxamine.
Arsenic Trioxide Injection Arsenic Trioxide Injection Fluvoxamine may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Cevimeline can be decreased when combined with Fluvoxamine.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Fluvoxamine.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Fluvoxamine.
Bendamustine Injection Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Fluvoxamine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Fluvoxamine.
Certolizumab Injection Certolizumab Injection The metabolism of Fluvoxamine can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Fluvoxamine.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Fluvoxamine.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Fluvoxamine.
Methylnaltrexone Injection Methylnaltrexone Injection Fluvoxamine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Fluvoxamine.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Fluvoxamine.
Naltrexone Injection Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Naltrexone.
Dexrazoxane Injection Dexrazoxane Injection Fluvoxamine may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Fluvoxamine.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Milnacipran.
Dexlansoprazole Dexlansoprazole The metabolism of Dexlansoprazole can be decreased when combined with Fluvoxamine.
Plerixafor Injection Plerixafor Injection Fluvoxamine may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Fluvoxamine.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Fluvoxamine.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Fluvoxamine.
Prasugrel Prasugrel The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Prasugrel.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Fluvoxamine.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Fluvoxamine.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Fluvoxamine can be decreased when combined with Tolvaptan.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Fluvoxamine.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Fluvoxamine.
Pralatrexate Injection Pralatrexate Injection Fluvoxamine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection The metabolism of Fluvoxamine can be decreased when combined with Palonosetron.
Saxagliptin Saxagliptin The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Saxagliptin.
Telavancin Injection Telavancin Injection Fluvoxamine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Fluvoxamine.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.
Topotecan Topotecan Fluvoxamine may decrease the excretion rate of Topotecan which could result in a higher serum level.
Golimumab Injection Golimumab Injection The metabolism of Fluvoxamine can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Fluvoxamine.
Asenapine Asenapine The serum concentration of Asenapine can be increased when it is combined with Fluvoxamine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Fluvoxamine.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Fluvoxamine.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Fluvoxamine.
Oxymorphone Oxymorphone The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Fluvoxamine.
Dabigatran Dabigatran The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Dabigatran.
Liraglutide Injection Liraglutide Injection The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Liraglutide.
Tocilizumab Injection Tocilizumab Injection The metabolism of Fluvoxamine can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Fluvoxamine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Fluvoxamine.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Fluvoxamine.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Lurasidone Lurasidone The metabolism of Lurasidone can be decreased when combined with Fluvoxamine.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Fluvoxamine.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Fluvoxamine.
Ipilimumab Injection Ipilimumab Injection Fluvoxamine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Fluvoxamine may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Fluvoxamine.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Fluvoxamine.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Fluvoxamine.
Rilpivirine Rilpivirine The metabolism of Fluvoxamine can be decreased when combined with Rilpivirine.
Potassium Iodide Potassium Iodide The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Fluvoxamine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Fluvoxamine.
Abiraterone Abiraterone The serum concentration of Fluvoxamine can be increased when it is combined with Abiraterone.
Rivaroxaban Rivaroxaban The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Fluvoxamine.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Fluvoxamine.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Fluvoxamine.
Clobazam Clobazam The metabolism of Clobazam can be decreased when combined with Fluvoxamine.
Vemurafenib Vemurafenib The serum concentration of Fluvoxamine can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Vismodegib can be decreased when combined with Fluvoxamine.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Fluvoxamine.
Deferiprone Deferiprone Fluvoxamine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Fluvoxamine.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Fluvoxamine.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Fluvoxamine.
Naloxone Injection Naloxone Injection Fluvoxamine may decrease the excretion rate of Naloxone which could result in a higher serum level.
Fondaparinux Injection Fondaparinux Injection The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Fondaparinux.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Fluvoxamine.
Iloprost Iloprost The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Iloprost.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Fluvoxamine.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Fluvoxamine.
Regorafenib Regorafenib The metabolism of Regorafenib can be decreased when combined with Fluvoxamine.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Fluvoxamine.
Teriflunomide Teriflunomide The serum concentration of Fluvoxamine can be decreased when it is combined with Teriflunomide.
Lorcaserin Lorcaserin The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Mecasermin.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Fluvoxamine.
Teduglutide Injection Teduglutide Injection Fluvoxamine may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Icosapent Ethyl Icosapent Ethyl The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Icosapent ethyl.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Fluvoxamine.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Fluvoxamine.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Fluvoxamine.
Pomalidomide Pomalidomide The serum concentration of Pomalidomide can be increased when it is combined with Fluvoxamine.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Fluvoxamine.
Apixaban Apixaban The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Apixaban.
Canagliflozin Canagliflozin The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Canagliflozin.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Fluvoxamine.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Fluvoxamine.
Trametinib Trametinib Fluvoxamine may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Fluvoxamine.
Ertapenem Injection Ertapenem Injection Fluvoxamine may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Fluvoxamine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Fluvoxamine.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Fluvoxamine.
Avanafil Avanafil The metabolism of Avanafil can be decreased when combined with Fluvoxamine.
Ketorolac Injection Ketorolac Injection The risk or severity of gastrointestinal bleeding can be increased when Ketorolac is combined with Fluvoxamine.
Simeprevir Simeprevir Simeprevir may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Sofosbuvir Sofosbuvir Fluvoxamine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Fluvoxamine.
Apremilast Apremilast The metabolism of Fluvoxamine can be increased when combined with Apremilast.
Droxidopa Droxidopa Fluvoxamine may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Fluvoxamine.
Siltuximab Injection Siltuximab Injection The metabolism of Fluvoxamine can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Albiglutide.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Fluvoxamine.
Belinostat Injection Belinostat Injection The metabolism of Fluvoxamine can be increased when combined with Belinostat.
Idelalisib Idelalisib The metabolism of Fluvoxamine can be decreased when combined with Idelalisib.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Fluvoxamine.
Oritavancin Injection Oritavancin Injection The metabolism of Fluvoxamine can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Empagliflozin.
Vorapaxar Vorapaxar The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Vorapaxar.
Hydrocodone Hydrocodone Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Suvorexant Suvorexant Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection Dulaglutide Injection The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Dulaglutide.
Edoxaban Edoxaban The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The metabolism of Fluvoxamine can be decreased when combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Fluvoxamine.
Methamphetamine Methamphetamine The metabolism of Fluvoxamine can be decreased when combined with Metamfetamine.
Tasimelteon Tasimelteon The serum concentration of Tasimelteon can be increased when it is combined with Fluvoxamine.
Lanreotide Injection Lanreotide Injection The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Lanreotide.
Pirfenidone Pirfenidone The serum concentration of Pirfenidone can be increased when it is combined with Fluvoxamine.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Fluvoxamine.
Secukinumab Injection Secukinumab Injection The metabolism of Fluvoxamine can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Risperidone can be decreased when combined with Fluvoxamine.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Fluvoxamine.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Fluvoxamine can be increased when combined with Insulin human.
Lenvatinib Lenvatinib Lenvatinib may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Naloxegol Naloxegol The metabolism of Naloxegol can be decreased when combined with Fluvoxamine.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Fluvoxamine.
Haloperidol Injection Haloperidol Injection The risk or severity of CNS depression can be increased when Fluvoxamine is combined with Haloperidol.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.
Ivabradine Ivabradine The metabolism of Ivabradine can be decreased when combined with Fluvoxamine.
Amiloride Amiloride Amiloride may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Fluvoxamine may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Fluvoxamine.
Flibanserin Flibanserin The metabolism of Flibanserin can be decreased when combined with Fluvoxamine.
Rolapitant Rolapitant The metabolism of Rolapitant can be decreased when combined with Fluvoxamine.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Fluvoxamine.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Fluvoxamine.
Ziprasidone Injection Ziprasidone Injection The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Ziprasidone.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Fluvoxamine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Fluvoxamine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Fluvoxamine can be increased when combined with Insulin degludec.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Fluvoxamine.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Fluvoxamine.
Osimertinib Osimertinib The serum concentration of Fluvoxamine can be decreased when it is combined with Osimertinib.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Fluvoxamine.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Fluvoxamine.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Fluvoxamine.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection Dexamethasone may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.
Defibrotide Injection Defibrotide Injection The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Defibrotide.
Brivaracetam Injection Brivaracetam Injection The risk or severity of adverse effects can be increased when Brivaracetam is combined with Fluvoxamine.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Fluvoxamine.
Cobicistat Cobicistat The metabolism of Cobicistat can be decreased when combined with Fluvoxamine.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Pimavanserin.
Obeticholic Acid Obeticholic Acid The metabolism of Fluvoxamine can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Fluvoxamine can be decreased when combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Fluvoxamine may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Fluvoxamine.
Lixisenatide Injection Lixisenatide Injection The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Lixisenatide.
Ribociclib Ribociclib The metabolism of Fluvoxamine can be decreased when combined with Ribociclib.
Parathyroid Hormone Injection Parathyroid Hormone Injection The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Fluvoxamine.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Fluvoxamine.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Fluvoxamine.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Fluvoxamine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Fluvoxamine.
Deflazacort Deflazacort The serum concentration of Deflazacort can be increased when it is combined with Fluvoxamine.
Safinamide Safinamide Safinamide may increase the serotonergic activities of Fluvoxamine.
Naldemedine Naldemedine Fluvoxamine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The metabolism of Fluvoxamine can be decreased when combined with Midostaurin.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Fluvoxamine.
Abaloparatide Injection Abaloparatide Injection The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Fluvoxamine.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Fluvoxamine.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Fluvoxamine.
Benznidazole Benznidazole Fluvoxamine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Fluvoxamine.
Delafloxacin Delafloxacin Fluvoxamine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Fluvoxamine.
Betrixaban Betrixaban The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Betrixaban.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Fluvoxamine.
Letermovir Letermovir The metabolism of Fluvoxamine can be decreased when combined with Letermovir.
Semaglutide Injection Semaglutide Injection The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Semaglutide.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Fluvoxamine.
Ertugliflozin Ertugliflozin The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide Apalutamide Fluvoxamine may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Fluvoxamine.
Lofexidine Lofexidine The therapeutic efficacy of Fluvoxamine can be increased when used in combination with Lofexidine.
Plazomicin Injection Plazomicin Injection Fluvoxamine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Fluvoxamine.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Fluvoxamine.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Fluvoxamine.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Fluvoxamine.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Fluvoxamine.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Fluvoxamine.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fluvoxamine.
Dacomitinib Dacomitinib The metabolism of Fluvoxamine can be decreased when combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Fluvoxamine.
Stiripentol Stiripentol The metabolism of Stiripentol can be decreased when combined with Fluvoxamine.
Gilteritinib Gilteritinib The therapeutic efficacy of Fluvoxamine can be decreased when used in combination with Gilteritinib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Fluvoxamine.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Fluvoxamine.
Rifamycin Rifamycin The metabolism of Fluvoxamine can be decreased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Fluvoxamine.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Fluvoxamine can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Fluvoxamine.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Caplacizumab.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Fluvoxamine.
Esomeprazole Injection Esomeprazole Injection The metabolism of Esomeprazole can be decreased when combined with Fluvoxamine.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Fluvoxamine.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Brexanolone is combined with Fluvoxamine.
Solriamfetol Solriamfetol The risk or severity of adverse effects can be increased when Solriamfetol is combined with Fluvoxamine.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Fluvoxamine.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Fluvoxamine.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Fluvoxamine.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Fluvoxamine.
Pitolisant Pitolisant The serum concentration of Fluvoxamine can be decreased when it is combined with Pitolisant.
Pretomanid Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Fluvoxamine.
Fedratinib Fedratinib The metabolism of Fedratinib can be decreased when combined with Fluvoxamine.
Lefamulin Lefamulin The serum concentration of Lefamulin can be increased when it is combined with Fluvoxamine.
Phenytoin Injection Phenytoin Injection The serum concentration of Fluvoxamine can be increased when it is combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The serum concentration of Fluvoxamine can be increased when it is combined with Fosphenytoin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Fluvoxamine.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Fluvoxamine.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Fluvoxamine.
Lumateperone Lumateperone The serum concentration of Fluvoxamine can be increased when it is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Fluvoxamine.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Fluvoxamine.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Fluvoxamine.
Cenobamate Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Fluvoxamine.
Pemigatinib Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Fluvoxamine.
Selumetinib Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Fluvoxamine.
Rimegepant Rimegepant The metabolism of Rimegepant can be decreased when combined with Fluvoxamine.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Fluvoxamine.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be increased when it is combined with Fluvoxamine.
Capmatinib Capmatinib The serum concentration of Capmatinib can be increased when it is combined with Fluvoxamine.
Lemborexant Lemborexant The serum concentration of Lemborexant can be increased when it is combined with Fluvoxamine.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Fenfluramine.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Fluvoxamine.
Octreotide Octreotide The risk or severity of hypoglycemia can be increased when Octreotide is combined with Fluvoxamine.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Fluvoxamine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Fluvoxamine can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Fluvoxamine.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Viloxazine.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Fluvoxamine.
Fenoprofen Fenoprofen The risk or severity of gastrointestinal bleeding can be increased when Fenoprofen is combined with Fluvoxamine.
Indomethacin Indomethacin The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Indomethacin.
Mefenamic Acid Mefenamic Acid The risk or severity of gastrointestinal bleeding can be increased when Mefenamic acid is combined with Fluvoxamine.
Naproxen Naproxen The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Naproxen.
Tolmetin Tolmetin The risk or severity of gastrointestinal bleeding can be increased when Tolmetin is combined with Fluvoxamine.
Sulindac Sulindac The risk or severity of gastrointestinal bleeding can be increased when Sulindac is combined with Fluvoxamine.
Trazodone Trazodone The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Fluvoxamine.
Isotretinoin Isotretinoin Fluvoxamine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Fluvoxamine may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Hydroxyurea Hydroxyurea The metabolism of Fluvoxamine can be decreased when combined with Hydroxyurea.
Floxuridine Floxuridine Fluvoxamine may decrease the excretion rate of Floxuridine which could result in a higher serum level.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Fluvoxamine.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Fluvoxamine.
Methotrexate Injection Methotrexate Injection The metabolism of Fluvoxamine can be decreased when combined with Methotrexate.
Levorphanol Levorphanol The risk or severity of serotonin syndrome can be increased when Levorphanol is combined with Fluvoxamine.
Primidone Primidone The metabolism of Fluvoxamine can be decreased when combined with Primidone.
Methsuximide Methsuximide The metabolism of Methsuximide can be decreased when combined with Fluvoxamine.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Diethylpropion.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Fluvoxamine.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Fluvoxamine.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Oxazepam.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Flurazepam.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clorazepic acid.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Lorazepam.
Carmustine Carmustine The metabolism of Carmustine can be decreased when combined with Fluvoxamine.
Amantadine Amantadine The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Amantadine.
Codeine Codeine The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Codeine.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Meprobamate.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Chlordiazepoxide.
Bromocriptine Bromocriptine The risk or severity of adverse effects can be increased when Bromocriptine is combined with Fluvoxamine.
Tranylcypromine Tranylcypromine Fluvoxamine may increase the serotonergic activities of Tranylcypromine.
Phenelzine Phenelzine Fluvoxamine may increase the serotonergic activities of Phenelzine.
Procarbazine Procarbazine Procarbazine may increase the serotonergic activities of Fluvoxamine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fluvoxamine.
Tetracycline Tetracycline Fluvoxamine may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Fluvoxamine.
Thioridazine Thioridazine The serum concentration of Thioridazine can be increased when it is combined with Fluvoxamine.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Fluvoxamine.
Bleomycin Bleomycin Fluvoxamine may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Fluvoxamine.
Sulfadiazine Sulfadiazine The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Sulfadiazine.
Oxycodone Oxycodone The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Fluvoxamine.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Fluvoxamine.
Oxybutynin Oxybutynin The metabolism of Fluvoxamine can be decreased when combined with Oxybutynin.
Benztropine Benztropine The metabolism of Benzatropine can be decreased when combined with Fluvoxamine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Fluvoxamine.
Ibuprofen Ibuprofen The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Ibuprofen.
Trihexyphenidyl Trihexyphenidyl Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Fluvoxamine.
Azathioprine Azathioprine The metabolism of Azathioprine can be decreased when combined with Fluvoxamine.
Fluphenazine Fluphenazine The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Fluphenazine.
Phentermine Phentermine The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Phentermine.
Methylphenidate Methylphenidate Fluvoxamine may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Amoxapine Amoxapine The metabolism of Amoxapine can be decreased when combined with Fluvoxamine.
Sulfasalazine Sulfasalazine The risk or severity of gastrointestinal bleeding can be increased when Sulfasalazine is combined with Fluvoxamine.
Hydrocortisone Hydrocortisone The metabolism of Hydrocortisone can be decreased when combined with Fluvoxamine.
Doxorubicin Doxorubicin The metabolism of Fluvoxamine can be decreased when combined with Doxorubicin.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.
Molindone Molindone The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Molindone.
Methyldopa Methyldopa Fluvoxamine may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Fluvoxamine.
Hydralazine Hydralazine Fluvoxamine may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine The metabolism of Fluvoxamine can be decreased when combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Fluvoxamine.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Clonazepam is combined with Fluvoxamine.
Loperamide Loperamide The metabolism of Fluvoxamine can be decreased when combined with Loperamide.
Promethazine Promethazine The metabolism of Fluvoxamine can be decreased when combined with Promethazine.
Meclofenamate Meclofenamate The risk or severity of gastrointestinal bleeding can be increased when Meclofenamic acid is combined with Fluvoxamine.
Daunorubicin Daunorubicin Fluvoxamine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Fluvoxamine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Fluvoxamine can be increased when combined with Griseofulvin.
Digoxin Digoxin Fluvoxamine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Loxapine.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Fluvoxamine.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Fluvoxamine.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Fluvoxamine.
Triamterene Triamterene The metabolism of Triamterene can be decreased when combined with Fluvoxamine.
Sulfinpyrazone Sulfinpyrazone Fluvoxamine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Chlorothiazide Chlorothiazide The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Chlorothiazide.
Chlorthalidone Chlorthalidone The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Chlorthalidone.
Metolazone Metolazone The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Metolazone.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Fluvoxamine.
Secobarbital Secobarbital The risk or severity of adverse effects can be increased when Secobarbital is combined with Fluvoxamine.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Fluvoxamine.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Fluvoxamine.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Fluvoxamine.
Probenecid Probenecid Fluvoxamine may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine The metabolism of Fluvoxamine can be decreased when combined with Quinidine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Fluvoxamine.
Isoniazid Isoniazid The metabolism of Fluvoxamine can be decreased when combined with Isoniazid.
Pyrazinamide Pyrazinamide Fluvoxamine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Rifampin Rifampin The metabolism of Fluvoxamine can be increased when combined with Rifampicin.
Disopyramide Disopyramide The metabolism of Disopyramide can be decreased when combined with Fluvoxamine.
Valproic Acid Valproic Acid The metabolism of Fluvoxamine can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Fluvoxamine.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Fluvoxamine.
Levothyroxine Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Fluvoxamine.
Liothyronine Liothyronine Fluvoxamine may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole The metabolism of Fluvoxamine can be decreased when combined with Methimazole.
Propylthiouracil Propylthiouracil The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Fluvoxamine.
Chlorpropamide Chlorpropamide The metabolism of Chlorpropamide can be decreased when combined with Fluvoxamine.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Fluvoxamine.
Tolazamide Tolazamide The metabolism of Tolazamide can be decreased when combined with Fluvoxamine.
Dextromethorphan Dextromethorphan The metabolism of Fluvoxamine can be decreased when combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Fluvoxamine is combined with Cyclobenzaprine.
Niacin Niacin The metabolism of Fluvoxamine can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Fluvoxamine.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.
Cyproheptadine Cyproheptadine The therapeutic efficacy of Fluvoxamine can be decreased when used in combination with Cyproheptadine.
Clemastine Clemastine The risk or severity of adverse effects can be increased when Clemastine is combined with Fluvoxamine.
Chlorpheniramine Chlorpheniramine The metabolism of Fluvoxamine can be decreased when combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Fluvoxamine.
Meclizine Meclizine The metabolism of Fluvoxamine can be decreased when combined with Meclizine.
Ethambutol Ethambutol Fluvoxamine may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Hydrochlorothiazide.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Dantrolene is combined with Fluvoxamine.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Fluvoxamine.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Fluvoxamine.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Fluvoxamine.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Disulfiram Disulfiram Fluvoxamine may decrease the excretion rate of Disulfiram which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The serum concentration of Propranolol can be increased when it is combined with Fluvoxamine.
Pseudoephedrine Pseudoephedrine The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Fluvoxamine.
Spironolactone Spironolactone Fluvoxamine may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Mercaptopurine Mercaptopurine The metabolism of Mercaptopurine can be decreased when combined with Fluvoxamine.
Phytonadione Phytonadione Fluvoxamine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Nadolol Nadolol The metabolism of Nadolol can be decreased when combined with Fluvoxamine.
Butorphanol Injection Butorphanol Injection The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Fluvoxamine.
Nalbuphine Injection Nalbuphine Injection The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Fluvoxamine.
Allopurinol Allopurinol Fluvoxamine may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Fluvoxamine.
Flavoxate Flavoxate Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Fluvoxamine.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Fluvoxamine.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Dacarbazine Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Fluvoxamine.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Fluvoxamine.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Ketoconazole Ketoconazole The metabolism of Fluvoxamine can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Pyrantel is combined with Fluvoxamine.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Fluvoxamine.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be decreased when combined with Fluvoxamine.
Dipyridamole Dipyridamole The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Dipyridamole.
Vinblastine Vinblastine The metabolism of Fluvoxamine can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Fluvoxamine.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.
Thiothixene Thiothixene The metabolism of Thiothixene can be decreased when combined with Fluvoxamine.
Aspirin Aspirin The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Acetylsalicylic acid.
Salsalate Salsalate The risk or severity of gastrointestinal bleeding can be increased when Salsalate is combined with Fluvoxamine.
Alprazolam Alprazolam The serum concentration of Alprazolam can be increased when it is combined with Fluvoxamine.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Temazepam.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Fluvoxamine.
Dicyclomine Dicyclomine Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Fluvoxamine.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Fluvoxamine.
Nifedipine Nifedipine The metabolism of Nifedipine can be decreased when combined with Fluvoxamine.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Fluvoxamine.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Fluvoxamine.
Atenolol Atenolol The metabolism of Atenolol can be decreased when combined with Fluvoxamine.
Pindolol Pindolol The metabolism of Fluvoxamine can be decreased when combined with Pindolol.
Cisplatin Injection Cisplatin Injection Fluvoxamine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal The risk or severity of gastrointestinal bleeding can be increased when Diflunisal is combined with Fluvoxamine.
Piroxicam Piroxicam The risk or severity of gastrointestinal bleeding can be increased when Piroxicam is combined with Fluvoxamine.
Bumetanide Bumetanide Fluvoxamine may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Streptozocin Streptozocin The metabolism of Fluvoxamine can be increased when combined with Streptozocin.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Fluvoxamine.
Glyburide Glyburide The metabolism of Fluvoxamine can be decreased when combined with Glyburide.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Fluvoxamine.
Indapamide Indapamide The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Indapamide.
Amoxicillin Amoxicillin Fluvoxamine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Nafcillin Injection Nafcillin Injection The metabolism of Fluvoxamine can be increased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Fluvoxamine may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Fluvoxamine.
Pentamidine Injection Pentamidine Injection The metabolism of Fluvoxamine can be decreased when combined with Pentamidine.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Labetalol Labetalol The metabolism of Fluvoxamine can be decreased when combined with Labetalol.
Auranofin Auranofin Fluvoxamine may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Gemfibrozil Gemfibrozil The metabolism of Gemfibrozil can be decreased when combined with Fluvoxamine.
Guanabenz Guanabenz The metabolism of Guanabenz can be decreased when combined with Fluvoxamine.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Ketoprofen Ketoprofen The risk or severity of gastrointestinal bleeding can be increased when Ketoprofen is combined with Fluvoxamine.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Pimozide Pimozide The risk or severity of QTc prolongation can be increased when Fluvoxamine is combined with Pimozide.
Flurbiprofen Flurbiprofen The risk or severity of gastrointestinal bleeding can be increased when Flurbiprofen is combined with Fluvoxamine.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Fluvoxamine.
Aztreonam Injection Aztreonam Injection Fluvoxamine may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone The metabolism of Buspirone can be decreased when combined with Fluvoxamine.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Fluvoxamine.
Ciprofloxacin Ciprofloxacin The metabolism of Fluvoxamine can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Fluvoxamine.
Diclofenac Diclofenac The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Diclofenac.
Fluoxetine Fluoxetine The serum concentration of Fluoxetine can be increased when it is combined with Fluvoxamine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The metabolism of Fluvoxamine can be decreased when combined with Interferon alfa-2b.
Clozapine Clozapine The serum concentration of Clozapine can be increased when it is combined with Fluvoxamine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Estazolam.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Fluvoxamine.
Ofloxacin Ofloxacin The metabolism of Fluvoxamine can be decreased when combined with Ofloxacin.
Didanosine Didanosine Fluvoxamine may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Fluvoxamine may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Clarithromycin Clarithromycin Fluvoxamine may decrease the excretion rate of Clarithromycin which could result in a higher serum level.
Etodolac Etodolac The risk or severity of gastrointestinal bleeding can be increased when Etodolac is combined with Fluvoxamine.
Felodipine Felodipine Fluvoxamine may decrease the excretion rate of Felodipine which could result in a higher serum level.
Fosinopril Fosinopril Fluvoxamine may decrease the excretion rate of Fosinopril which could result in a higher serum level.
Nabumetone Nabumetone The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Nabumetone.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Fluvoxamine.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Fluvoxamine.
Lisinopril Lisinopril Fluvoxamine may decrease the excretion rate of Lisinopril which could result in a higher serum level.
Oxaprozin Oxaprozin The risk or severity of gastrointestinal bleeding can be increased when Oxaprozin is combined with Fluvoxamine.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Fluvoxamine.
Bisoprolol Bisoprolol Fluvoxamine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Zolpidem Zolpidem Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Fluvoxamine.
Isradipine Isradipine Fluvoxamine may decrease the excretion rate of Isradipine which could result in a higher serum level.
Omeprazole Omeprazole The metabolism of Omeprazole can be decreased when combined with Fluvoxamine.
Cisapride Cisapride The metabolism of Fluvoxamine can be decreased when combined with Cisapride.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Gabapentin.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Fluvoxamine.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Fluvoxamine.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Nefazodone can be decreased when combined with Fluvoxamine.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Lamotrigine.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Fluvoxamine.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Tramadol Tramadol The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Fluvoxamine.
Vinorelbine Injection Vinorelbine Injection The metabolism of Fluvoxamine can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be decreased when combined with Fluvoxamine.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Fluvoxamine.
Nicardipine Nicardipine The metabolism of Nicardipine can be decreased when combined with Fluvoxamine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Bupropion is combined with Fluvoxamine.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Fluvoxamine.
Saquinavir Saquinavir Fluvoxamine may decrease the excretion rate of Saquinavir which could result in a higher serum level.
Metformin Metformin The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Metformin.
Dalteparin Injection Dalteparin Injection The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Dalteparin.
Nisoldipine Nisoldipine The metabolism of Nisoldipine can be decreased when combined with Fluvoxamine.
Lamivudine Lamivudine Fluvoxamine may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Fluvoxamine.
Acarbose Acarbose The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Acarbose.
Glimepiride Glimepiride The metabolism of Glimepiride can be decreased when combined with Fluvoxamine.
Gemcitabine Injection Gemcitabine Injection Fluvoxamine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Indinavir Indinavir Fluvoxamine may decrease the excretion rate of Indinavir which could result in a higher serum level.
Ritonavir Ritonavir The serum concentration of Fluvoxamine can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Fluvoxamine.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Meropenem Injection Meropenem Injection Fluvoxamine may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Fluvoxamine.
Zafirlukast Zafirlukast The metabolism of Fluvoxamine can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Fluvoxamine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine Fluvoxamine may increase the serotonergic activities of Mirtazapine.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Topiramate.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Fluvoxamine.
Valsartan Valsartan The metabolism of Valsartan can be decreased when combined with Fluvoxamine.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Fluvoxamine can be increased when combined with Insulin lispro.
Pramipexole Pramipexole Fluvoxamine may increase the sedative activities of Pramipexole.
Donepezil Donepezil The metabolism of Fluvoxamine can be decreased when combined with Donepezil.
Nelfinavir Nelfinavir The metabolism of Fluvoxamine can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Fluvoxamine.
Loratadine Loratadine Fluvoxamine may decrease the excretion rate of Loratadine which could result in a higher serum level.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Fluvoxamine.
Nilutamide Nilutamide Fluvoxamine may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Fluvoxamine.
Selegiline Selegiline Fluvoxamine may increase the serotonergic activities of Selegiline.
Bicalutamide Bicalutamide The metabolism of Fluvoxamine can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Fluvoxamine.
Propafenone Propafenone The metabolism of Propafenone can be decreased when combined with Fluvoxamine.
Irbesartan Irbesartan The metabolism of Irbesartan can be decreased when combined with Fluvoxamine.
Tamsulosin Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Fluvoxamine.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Ropinirole.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Fluvoxamine.
Quetiapine Quetiapine The metabolism of Quetiapine can be decreased when combined with Fluvoxamine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Fluvoxamine.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Fluvoxamine.
Tolcapone Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Fluvoxamine.
Citalopram Citalopram The serum concentration of Citalopram can be increased when it is combined with Fluvoxamine.
Capecitabine Capecitabine The metabolism of Capecitabine can be decreased when combined with Fluvoxamine.
Efavirenz Efavirenz The metabolism of Fluvoxamine can be decreased when combined with Efavirenz.
Abacavir Abacavir Fluvoxamine may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Fluvoxamine.
Pioglitazone Pioglitazone The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Pioglitazone.
Celecoxib Celecoxib The risk or severity of bleeding can be increased when Celecoxib is combined with Fluvoxamine.
Rosiglitazone Rosiglitazone The metabolism of Rosiglitazone can be decreased when combined with Fluvoxamine.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Fluvoxamine.
Thalidomide Thalidomide Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir Oseltamivir Fluvoxamine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
Balsalazide Balsalazide The risk or severity of gastrointestinal bleeding can be increased when Balsalazide is combined with Fluvoxamine.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Fluvoxamine.
Galantamine Galantamine The metabolism of Galantamine can be decreased when combined with Fluvoxamine.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Fluvoxamine.
Rabeprazole Rabeprazole The metabolism of Rabeprazole can be decreased when combined with Fluvoxamine.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Fluvoxamine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists